Masimo Current Ratio 2007-2019 | MASI
Current and historical current ratio for Masimo (MASI) from 2007 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Masimo current ratio for the three months ending June 30, 2019 was 6.35.
| Masimo Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2019-06-30 | $0.86B | $0.14B | 6.35 |
| 2019-03-31 | $0.85B | $0.12B | 7.02 |
| 2018-12-31 | $0.79B | $0.15B | 5.33 |
| 2018-09-30 | $0.74B | $0.14B | 5.12 |
| 2018-06-30 | $0.65B | $0.13B | 5.05 |
| 2018-03-31 | $0.60B | $0.13B | 4.55 |
| 2017-12-31 | $0.56B | $0.13B | 4.32 |
| 2017-09-30 | $0.55B | $0.17B | 3.17 |
| 2017-06-30 | $0.57B | $0.15B | 3.89 |
| 2017-03-31 | $0.56B | $0.20B | 2.75 |
| 2016-12-31 | $0.51B | $0.22B | 2.30 |
| 2016-09-30 | $0.33B | $0.14B | 2.25 |
| 2016-06-30 | $0.30B | $0.12B | 2.46 |
| 2016-03-31 | $0.32B | $0.12B | 2.65 |
| 2015-12-31 | $0.30B | $0.13B | 2.26 |
| 2015-09-30 | $0.30B | $0.11B | 2.66 |
| 2015-06-30 | $0.31B | $0.11B | 2.71 |
| 2015-03-31 | $0.32B | $0.12B | 2.69 |
| 2014-12-31 | $0.30B | $0.12B | 2.40 |
| 2014-09-30 | $0.30B | $0.24B | 1.25 |
| 2014-06-30 | $0.27B | $0.17B | 1.59 |
| 2014-03-31 | $0.29B | $0.10B | 2.96 |
| 2013-12-31 | $0.27B | $0.10B | 2.62 |
| 2013-09-30 | $0.26B | $0.10B | 2.53 |
| 2013-06-30 | $0.24B | $0.09B | 2.54 |
| 2013-03-31 | $0.23B | $0.10B | 2.37 |
| 2012-12-31 | $0.22B | $0.09B | 2.45 |
| 2012-09-30 | $0.26B | $0.08B | 3.08 |
| 2012-06-30 | $0.27B | $0.08B | 3.55 |
| 2012-03-31 | $0.27B | $0.09B | 2.98 |
| 2011-12-31 | $0.26B | $0.08B | 3.46 |
| 2011-09-30 | $0.28B | $0.07B | 4.19 |
| 2011-06-30 | $0.25B | $0.06B | 4.08 |
| 2011-03-31 | $0.23B | $0.06B | 3.67 |
| 2010-12-31 | $0.22B | $0.07B | 3.10 |
| 2010-09-30 | $0.25B | $0.07B | 3.55 |
| 2010-06-30 | $0.23B | $0.06B | 3.54 |
| 2010-03-31 | $0.22B | $0.07B | 3.01 |
| 2009-12-31 | $0.29B | $0.06B | 4.87 |
| 2009-09-30 | $0.28B | $0.06B | 4.87 |
| 2009-06-30 | $0.25B | $0.05B | 4.75 |
| 2009-03-31 | $0.24B | $0.06B | 4.02 |
| 2008-12-31 | $0.23B | $0.07B | 3.54 |
| 2008-09-30 | $0.22B | $0.05B | 4.06 |
| 2008-06-30 | $0.20B | $0.06B | 3.39 |
| 2008-03-31 | $0.17B | $0.06B | 3.18 |
| 2007-12-31 | $0.18B | $0.06B | 2.97 |
| 2007-09-30 | $0.18B | $0.06B | 2.77 |
| 2007-06-30 | $0.12B | $0.07B | 1.78 |
| 2007-03-31 | $0.00B | 0.00 | |
| 2006-09-30 | $0.00B | 0.00 | |
| 2006-06-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.081B | $0.858B |
| Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $118.240B | 25.19 |
| Intuitive Surgical (ISRG) | United States | $61.021B | 53.37 |
| Edwards Lifesciences (EW) | United States | $44.736B | 43.54 |
| IDEXX Laboratories (IDXX) | United States | $23.571B | 59.13 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $21.210B | 14.24 |
| Olympus (OCPNY) | Japan | $17.714B | 133.03 |
| Teleflex (TFX) | United States | $15.798B | 33.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.350B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $14.145B | 38.13 |
| DexCom (DXCM) | United States | $14.133B | 209.45 |
| Hologic (HOLX) | United States | $13.365B | 21.10 |
| STERIS (STE) | Ireland | $12.346B | 28.48 |
| Varian Medical Systems (VAR) | United States | $10.559B | 25.26 |
| ABIOMED (ABMD) | United States | $8.727B | 49.95 |
| SARTORIUS AG (SARTF) | Germany | $5.614B | 49.88 |
| Integra LifeSciences Holdings (IART) | United States | $5.208B | 23.24 |
| Penumbra (PEN) | United States | $5.143B | 184.76 |
| Globus Medical (GMED) | United States | $5.089B | 32.30 |
| Elekta AB (EKTAY) | Sweden | $5.065B | 38.99 |
| LivaNova (LIVN) | United Kingdom | $3.820B | 29.13 |
| Cantel Medical (CMD) | United States | $3.717B | 37.71 |
| Tandem Diabetes Care (TNDM) | United States | $3.610B | 0.00 |
| Nevro (NVRO) | United States | $2.758B | 0.00 |
| Wright Medical Group (WMGI) | Netherlands | $2.688B | 235.78 |
| Glaukos (GKOS) | United States | $2.645B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.598B | 18.38 |
| Nihon Kohden (NHNKY) | Japan | $2.483B | 24.98 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.748B | 32.42 |
| Veracyte (VCYT) | United States | $1.262B | 0.00 |
| OPKO Health (OPK) | United States | $1.262B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $1.160B | 0.00 |
| Silk Road Medical (SILK) | United States | $1.103B | 0.00 |
| CryoLife (CRY) | United States | $1.086B | 103.39 |
| Inogen (INGN) | United States | $1.077B | 26.39 |
| Natus Medical (NTUS) | United States | $1.060B | 24.69 |
| Luminex (LMNX) | United States | $0.999B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.995B | 45.99 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.978B | 30.71 |
| Tactile Systems Technology (TCMD) | United States | $0.941B | 116.21 |
| Pacific Biosciences Of California (PACB) | United States | $0.864B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.701B | 22.82 |
| OrthoPediatrics (KIDS) | United States | $0.578B | 0.00 |
| Intersect ENT (XENT) | United States | $0.572B | 0.00 |
| AxoGen (AXGN) | United States | $0.558B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.535B | 0.00 |
| Si-Bone (SIBN) | United States | $0.488B | 0.00 |
| Fluidigm (FLDM) | United States | $0.403B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.379B | 14.56 |
| Alphatec Holdings (ATEC) | United States | $0.352B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.345B | 0.00 |
| Sientra (SIEN) | United States | $0.344B | 0.00 |
| ViewRay (VRAY) | United States | $0.336B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.290B | 48.90 |
| Accuray (ARAY) | United States | $0.257B | 0.00 |
| IRadimed (IRMD) | United States | $0.255B | 42.40 |
| SeaSpine Holdings (SPNE) | United States | $0.231B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.229B | 34.44 |
| Neuronetics (STIM) | United States | $0.196B | 0.00 |
| ConforMIS (CFMS) | United States | $0.133B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.129B | 63.57 |
| T2 Biosystems (TTOO) | United States | $0.128B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.115B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.101B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.072B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.071B | 0.00 |
| Vermillion (VRML) | United States | $0.052B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.046B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.040B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.039B | 0.00 |
| Neovasc (NVCN) | Canada | $0.031B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.026B | 0.00 |
| Nuvectra (NVTR) | United States | $0.026B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.023B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.023B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.019B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.016B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.013B | 0.00 |
| OBALON THERPTCS (OBLN) | United States | $0.012B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.012B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.011B | 0.00 |
| Dynatronics (DYNT) | United States | $0.010B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.010B | 0.00 |
| Avinger (AVGR) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.005B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.005B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.000B | 0.00 |
